Europe Next Generation Sequencing (NGS) Market
Description
Europe Next Generation Sequencing (NGS) Market
The Europe next generation sequencing (NGS) market is expected to reach USD 9.98 billion by 2031 from USD 3.42 billion in 2023, growing at a CAGR of 15.0% in the forecast period of 2024 to 2031.
Market Segmentation
Europe Next Generation Sequencing (NGS) Market, By Product & Service (Consumables, Services, and Instruments), Technology (Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Others), Application (Pharmaceuticals Microbiology, Drug & Biomarker Discovery, Diagnostics, Precision Medicine, Agricultural & Animal Research, Food Pathogen Screening, and Others), End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Clinics, Clinical Laboratories, Contract Research Organizations (CROS), and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.K., Germany, France, Spain, Italy, Belgium, Russia, Switzerland, Netherlands, Turkey, rest of Europe) - Industry Trends and Forecast to 2031
Overview of Europe Next Generation Sequencing (NGS) Market Dynamics
Drivers
• Increase in the adoption of genome-focused pharmacology
• Wide product portfolio offered by major players
• Use of next generation sequencing in drug development
• Increase trend towards personalized medication
Restraints
• High cost of installation and maintenance of equipment's in the laboratory
• Complexity during implementation of NGS in the clinical lab
Opportunities
• Strategic initiatives by the key market players
• Increasing advancement in NGS technology
• Increasing applications of NGS in clinical diagnostics
Challenges
• Lack of skilled professionals to perform NGS
• Data privacy and security
Market Players
The key market players operating in the Europe next generation sequencing (NGS) market are listed below:
• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• QIAGEN
• Merck KGaA
• Charles River Laboratories
• Revvity
• Promega Corporation.
• Agilent Technologies, Inc.
• Takara Bio Inc.
• Eurofins Scientific
• Hamilton Company
• BGI
• Azenta US, Inc.
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc.
• PacBio.
• Macrogen, Inc.
• Gilson Incorporated
• New England Biolabs
• Oxford Nanopore Technologies plc.
• LGC Biosearch Technologies
• PCR Biosystems
• ACT Genomics
• Quantabio
• DNASTAR
• NimaGen.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
278 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The Europe Next Generation Sequencing (Ngs) Market
- 1.4 Currency And Pricing
- 1.5 Limitations
- 1.6 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 DBMR Tripod Data Validation Model
- 2.5 Primary Interviews With Key Opinion Leaders
- 2.6 Multivariate Modelling
- 2.7 Market Application Coverage Grid
- 2.8 Product Lifeline Curve
- 2.9 DBMR Market Position Grid
- 2.10 Vendor Share Analysis
- 2.11 Secondary Sources
- 2.12 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestel Analysis
- 4.2 Porters Five Forces
- 5 Market Overview
- 5.1 Drivers
- 5.1.1 Increase In The Adoption Of Genome-focused Pharmacology
- 5.1.2 Wide Product Portfolio Offered By Major Players
- 5.1.3 Use Of Next Generation Sequencing In Drug Development
- 5.1.4 Increase Trend Towards Personalized Medication
- 5.2 Restraints
- 5.2.1 High Cost Of Installation And Maintenance Of Equipment’s In The Laboratory
- 5.2.2 Complexity During Implementation Of Ngs In The Clinical Lab
- 5.3 Opportunities
- 5.3.1 Strategic Initiatives By The Key Market Players
- 5.3.2 Increasing Advancement In Ngs Technology
- 5.3.3 Increasing Applications Of Ngs In Clinical Diagnostics
- 5.4 Challenges
- 5.4.1 Lack Of Skilled Professionals To Perform Ngs
- 5.4.2 Data Privacy And Security
- 6 Europe Next Generation Sequencing (Ngs) Market, By Product And Service
- 6.1 Overview
- 6.2 Consumables
- 6.2.1 Library Preparation Consumables
- 6.2.2 Sample Preparation Consumables
- 6.3 Services
- 6.3.1 Sequencing Services
- 6.3.1.1 Rna Sequencing
- 6.3.1.2 Dna Sequencing
- 6.3.1.2.1 Whole Genome Sequencing
- 6.3.1.2.2 Whole Exome Sequencing
- 6.3.1.2.3 Targeted Sequencing
- 6.3.1.2.4 Chip Sequencing
- 6.3.1.2.5 De Novo Sequencing
- 6.3.1.2.6 Others
- 6.3.2 Data Management Services
- 6.3.2.1 Ngs Storage, Management And Cloud Computing Solutions
- 6.3.2.2 Ngs Data Analysis Software And Workbenches
- 6.3.2.3 Ngs Data Analysis Services
- 6.4 Instruments
- 6.4.1 Benchtop
- 6.4.2 Standalone
- 6.4.2.1 Automated
- 6.4.2.2 Semi-automated
- 6.4.2.3 Manual
- 6.4.2.3.1 Workstation/Platform
- 6.4.2.3.2 System
- 7 Europe Next Generation Sequencing (Ngs) Market, By Technology
- 7.1 Overview
- 7.2 Sequencing By Synthesis (Sbs)
- 7.2.1 Pyrosequencing
- 7.2.2 Ion Semi Conductor Sequencing
- 7.2.3 Nanopore Sequencing
- 7.2.4 Single-molecule-real-time Sequencing (Smrt)
- 7.3 Sequencing By Ligation (Sbl)
- 7.4 Others
- 8 Europe Next Generation Sequencing (Ngs) Market, By Application
- 8.1 Overview
- 8.2 Pharmaceuticals Microbiology
- 8.2.1 Microbial Identification/Detection
- 8.2.2 Targeted Sequencing
- 8.2.3 Cell Line Characterization
- 8.2.4 Antimicrobial Resistance And Predicting Antimicrobial Susceptibilities
- 8.2.5 Strain Subtyping
- 8.2.6 Others
- 8.2.6.1 Sequencing By Synthesis (Sbs)
- 8.2.6.2 Sequencing By Ligation (Sbl)
- 8.2.6.3 Others
- 8.3 Drug & Biomarker Discovery
- 8.3.1 Sequencing By Synthesis (Sbs)
- 8.3.2 Sequencing By Ligation (Sbl)
- 8.3.3 Others
- 8.4 Diagnostics
- 8.4.1 Cancer Diagnostics
- 8.4.2 Infectious Disease Diagnostics
- 8.4.3 Reproductive Health Diagnostics
- 8.4.4 Other Diagnostic Applications
- 8.4.4.1 Sequencing By Synthesis (Sbs)
- 8.4.4.2 Sequencing By Ligation (Sbl)
- 8.4.5 Others
- 8.5 Precision Medicine
- 8.5.1 Sequencing By Synthesis (Sbs)
- 8.5.2 Sequencing By Ligation (Sbl)
- 8.5.3 Others
- 8.6 Agricultural & Animal Research
- 8.6.1 Sequencing By Synthesis (Sbs)
- 8.6.2 Sequencing By Ligation (Sbl)
- 8.6.3 Others
- 8.7 Food Pathogen Screening
- 8.8 Others
- 9 Europe Next Generation Sequencing (Ngs) Market, By End User
- 9.1 Overview
- 9.2 Pharmaceutical & Biotechnology Companies
- 9.3 Academic & Research Institutes
- 9.4 Hospitals & Clinics
- 9.5 Clinical Laboratories
- 9.6 Contract Research Organizations (Cros)
- 9.7 Others
- 10 Europe Next Generation Sequencing (Ngs) Market, By Distribution Channel
- 10.1 Overview
- 10.2 Direct Tender
- 10.3 Retail Sales
- 10.3.1 Offline
- 10.3.2 Online
- 10.4 Others
- 11 Europe Next Generation Sequencing (Ngs) Market, By Region
- 11.1 Europe
- 11.1.1 U.K.
- 11.1.2 Germany
- 11.1.3 France
- 11.1.4 Spain
- 11.1.5 Italy
- 11.1.6 Belgium
- 11.1.7 Russia
- 11.1.8 Switzerland
- 11.1.9 Netherlands
- 11.1.10 Turkey
- 11.1.11 Rest Of Europe
- 12 Europe Next Generation Sequencing (Ngs) Market: Company Landscape
- 12.1 Company Share Analysis: Europe
- 13 Swot Analysis
- 14 Company Profiling
- 14.1 Illumina, Inc.
- 14.1.1 Company Snapshot
- 14.1.2 Revenueanalysis
- 14.1.3 Company Share Analysis
- 14.1.4 Product Portfolio
- 14.1.5 Recent Developments
- 14.2 Thermo Fisher Scientific Inc.
- 14.2.1 Company Snapshot
- 14.2.2 Revenue Analysis
- 14.2.3 Company Share Analysis
- 14.2.4 Product Portfolio
- 14.2.5 Recent Developments
- 14.3 Qiagen
- 14.3.1 Company Snapshot
- 14.3.2 Revenue Analysis
- 14.3.3 Company Share Analysis
- 14.3.4 Product Portfolio
- 14.3.5 Recent Developments
- 14.4 Merck Kgaa
- 14.4.1 Company Snapshot
- 14.4.2 Revenue Analysis
- 14.4.3 Company Share Analysis
- 14.4.4 Product Portfolio
- 14.4.5 Recent Development
- 14.5 Charles River Laboratories
- 14.5.1 Company Snapshot
- 14.5.2 Revenue Analysis
- 14.5.3 Company Share Analysis
- 14.5.4 Product Portfolio
- 14.5.5 Recent Developments
- 14.6 Act Genomics
- 14.6.1 Company Snapshot
- 14.6.2 Product Portfolio
- 14.6.3 Recent Developments
- 14.7 Agilent Technologies, Inc.
- 14.7.1 Company Snapshot
- 14.7.2 Revenue Analysis
- 14.7.3 Product Portfolio
- 14.7.4 Recent Development
- 14.8 Azenta Us, Inc.
- 14.8.1 Company Snapshot
- 14.8.2 Revenue Analysis
- 14.8.3 Product Portfolio
- 14.8.4 Recent Development
- 14.9 Beckman Coulter, Inc.
- 14.9.1 Company Snapshot
- 14.9.2 Product Portfolio
- 14.9.3 Recent Developments
- 14.10 Bio-rad Laboratories, Inc.
- 14.10.1 Company Snapshot
- 14.10.2 Revenue Analysis
- 14.10.3 Product Portfolio
- 14.10.4 Recent Developments
- 14.11 Bgi (A Subsidiairy Of Bgi Group) (2024)
- 14.11.1 Company Snapshot
- 14.11.2 Product Portfolio
- 14.11.3 Recent Development
- 14.12 Dnastar
- 14.12.1 Company Snapshot
- 14.12.2 Product Portfolio
- 14.12.3 Recent Development
- 14.13 Eurofins Scientific
- 14.13.1 Company Snapshot
- 14.13.2 Revenue Analysis
- 14.13.3 Product Portfolio
- 14.13.4 Recent Developments
- 14.14 Gilson Incorporated
- 14.14.1 Company Snapshot
- 14.14.2 Product Portfolio
- 14.14.3 Recent Development
- 14.15 Hamilton Company
- 14.15.1 Company Snapshot
- 14.15.2 Product Portfolio
- 14.15.3 Recent Development
- 14.16 Lgc Biosearch Technologies
- 14.16.1 Company Snapshot
- 14.16.2 Product Portfolio
- 14.16.3 Recent Developments
- 14.17 Macrogen, Inc.
- 14.17.1 Company Snapshot
- 14.17.2 Revenue Analysis
- 14.17.3 Product Portfolio
- 14.17.4 Recent Development
- 14.18 New England Biolabs
- 14.18.1 Company Snapshot
- 14.18.2 Product Portfolio
- 14.18.3 Recent Development
- 14.19 Nimagen
- 14.19.1 Company Snapshot
- 14.19.2 Product Portfolio
- 14.19.3 Recent Development
- 14.20 Oxford Nanopore Technologies Plc.
- 14.20.1 Company Snapshot
- 14.20.2 Revenue Analysis
- 14.20.3 Product Portfolio
- 14.20.4 Recent Developments
- 14.21 Pacbio.
- 14.21.1 Company Snapshot
- 14.21.2 Revenue Analysis
- 14.21.3 Product Portfolio
- 14.21.4 Recent Developments
- 14.22 Pcr Biosystems
- 14.22.1 Company Snapshot
- 14.22.2 Product Portfolio
- 14.22.3 Recent Developments
- 14.23 Promega Corporation.
- 14.23.1 Company Snapshot
- 14.23.2 Product Portfolio
- 14.23.3 Recent Developments
- 14.24 Quantabio
- 14.24.1 Company Snapshot
- 14.24.2 Product Portfolio
- 14.24.3 Recent Development
- 14.25 Revvity
- 14.25.1 Company Snapshot
- 14.25.2 Revenue Analysis
- 14.25.3 Product Portfolio
- 14.25.4 Recent Development
- 14.26 Takara Bio Inc.
- 14.26.1 Company Snapshot
- 14.26.2 Revenue Analysis
- 14.26.3 Product Portfolio
- 14.26.4 Recent Developments
- 15 Questionnaire
- 16 Related Reports
- Table 1 Instrument Cost Per Run
- Table 2 Platform /Company Cost Per Run
- Table 3 Europe Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 4 Europe Consumables In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 5 Europe Consumables In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 6 Europe Services In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 7 Europe Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 8 Europe Sequencing Services In Next Generation Sequencing (Ngs) Market, By Sample, 2022-2031 (Usd Million)
- Table 9 Europe Sequencing Services In Next Generation Sequencing (Ngs) Market, By Method, 2022-2031 (Usd Million)
- Table 10 Europe Data Management Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 11 Europe Instruments In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 12 Europe Instruments In Next Generation Sequencing (Ngs) Market, By Modality, 2022-2031 (Usd Million)
- Table 13 Europe Instruments In Next Generation Sequencing (Ngs) Market, By Mode, 2022-2031 (Usd Million)
- Table 14 Europe Instruments In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million)
- Table 15 Europe Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 16 Europe Consumables In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 17 Europe Sequencing By Synthesis (Sbs) In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 18 Europe Sequencing By Ligation (Sbl) In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 19 Europe Others In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 20 Europe Next Generation Sequencing (Ngs) Market, By Application, 2022-2031 (Usd Million)
- Table 21 Europe Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 22 Europe Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million)
- Table 23 Europe Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 24 Europe Drug & Biomarker Discovery In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 25 Europe Drug & Biomarker Discovery In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 26 Europe Diagnostics In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 27 Europe Diagnostics In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million)
- Table 28 Europe Diagnostics In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 29 Europe Precision Medicine In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 30 Europe Precision Medicine In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 31 Europe Agricultural & Animal Research In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 32 Europe Agricultural & Animal Research In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 33 Europe Food Pathogen Screening In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 34 Europe Others In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 35 Europe Next Generation Sequencing (Ngs) Market, By End User, 2022-2031 (Usd Million)
- Table 36 Europe Pharmaceutical & Biotechnology Companies In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 37 Europe Academic & Research Institutes In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 38 Europe Hospitals & Clinics In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 39 Europe Clinical Laboratories In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 40 Europe Contract Research Organizations (Cros) In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 41 Europe Others In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 42 Europe Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 43 Europe Direct Tender In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 44 Europe Retail Sales In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 45 Europe Retail Sales In Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 46 Europe Others In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million)
- Table 47 Europe Next Generation Sequencing (Ngs) Market, By Country, 2022-2031 (Usd Million)
- Table 48 Europe Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 49 Europe Consumables In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 50 Europe Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 51 Europe Sequencing Services In Next Generation Sequencing (Ngs) Market, By Sample, 2022-2031 (Usd Million)
- Table 52 Europe Sequencing Services In Next Generation Sequencing (Ngs) Market, By Method, 2022-2031 (Usd Million)
- Table 53 Europe Data Management Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 54 Europe Instruments In Next Generation Sequencing (Ngs) Market, By Modality, 2022-2031 (Usd Million)
- Table 55 Europe Instruments In Next Generation Sequencing (Ngs) Market, By Mode, 2022-2031 (Usd Million)
- Table 56 Europe Instruments In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million)
- Table 57 Europe Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 58 Europe Sequencing By Synthesis (Sbs) In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 59 Europe Next Generation Sequencing (Ngs) Market, By Application, 2022-2031 (Usd Million)
- Table 60 Europe Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million)
- Table 61 Europe Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 62 Europe Drug & Biomarker Discovery In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 63 Europe Diagnostics In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million)
- Table 64 Europe Diagnostics In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 65 Europe Precision Medicine In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 66 Europe Agricultural & Animal Research In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 67 Europe Next Generation Sequencing (Ngs) Market, By End User, 2022-2031 (Usd Million)
- Table 68 Europe Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 69 Europe Retail Sales In Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 70 U.K. Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 71 U.K. Consumables In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 72 U.K. Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 73 U.K. Sequencing Services In Next Generation Sequencing (Ngs) Market, By Sample, 2022-2031 (Usd Million)
- Table 74 U.K. Sequencing Services In Next Generation Sequencing (Ngs) Market, By Method, 2022-2031 (Usd Million)
- Table 75 U.K. Data Management Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 76 U.K. Instruments In Next Generation Sequencing (Ngs) Market, By Modality, 2022-2031 (Usd Million)
- Table 77 U.K. Instruments In Next Generation Sequencing (Ngs) Market, By Mode, 2022-2031 (Usd Million)
- Table 78 U.K. Instruments In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million)
- Table 79 U.K. Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 80 U.K. Sequencing By Synthesis (Sbs) In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 81 U.K. Next Generation Sequencing (Ngs) Market, By Application, 2022-2031 (Usd Million)
- Table 82 U.K. Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million)
- Table 83 U.K. Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 84 U.K. Drug & Biomarker Discovery In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 85 U.K. Diagnostics In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million)
- Table 86 U.K. Diagnostics In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 87 U.K. Precision Medicine In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 88 U.K. Agricultural & Animal Research In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 89 U.K. Next Generation Sequencing (Ngs) Market, By End User, 2022-2031 (Usd Million)
- Table 90 U.K. Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 91 U.K. Retail Sales In Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 92 Germany Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 93 Germany Consumables In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 94 Germany Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 95 Germany Sequencing Services In Next Generation Sequencing (Ngs) Market, By Sample, 2022-2031 (Usd Million)
- Table 96 Germany Sequencing Services In Next Generation Sequencing (Ngs) Market, By Method, 2022-2031 (Usd Million)
- Table 97 Germany Data Management Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 98 Germany Instruments In Next Generation Sequencing (Ngs) Market, By Modality, 2022-2031 (Usd Million)
- Table 99 Germany Instruments In Next Generation Sequencing (Ngs) Market, By Mode, 2022-2031 (Usd Million)
- Table 100 Germany Instruments In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million)
- Table 101 Germany Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 102 Germany Sequencing By Synthesis (Sbs) In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 103 Germany Next Generation Sequencing (Ngs) Market, By Application, 2022-2031 (Usd Million)
- Table 104 Germany Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million)
- Table 105 Germany Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 106 Germany Drug & Biomarker Discovery In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 107 Germany Diagnostics In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million)
- Table 108 Germany Diagnostics In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 109 Germany Precision Medicine In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 110 Germany Agricultural & Animal Research In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 111 Germany Next Generation Sequencing (Ngs) Market, By End User, 2022-2031 (Usd Million)
- Table 112 Germany Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 113 Germany Retail Sales In Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 114 France Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 115 France Consumables In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 116 France Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 117 France Sequencing Services In Next Generation Sequencing (Ngs) Market, By Sample, 2022-2031 (Usd Million)
- Table 118 France Sequencing Services In Next Generation Sequencing (Ngs) Market, By Method, 2022-2031 (Usd Million)
- Table 119 France Data Management Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 120 France Instruments In Next Generation Sequencing (Ngs) Market, By Modality, 2022-2031 (Usd Million)
- Table 121 France Instruments In Next Generation Sequencing (Ngs) Market, By Mode, 2022-2031 (Usd Million)
- Table 122 France Instruments In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million)
- Table 123 France Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 124 France Sequencing By Synthesis (Sbs) In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 125 France Next Generation Sequencing (Ngs) Market, By Application, 2022-2031 (Usd Million)
- Table 126 France Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million)
- Table 127 France Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 128 France Drug & Biomarker Discovery In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 129 France Diagnostics In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 130 France Precision Medicine In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 131 France Agricultural & Animal Research In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 132 France Next Generation Sequencing (Ngs) Market, By End User, 2022-2031 (Usd Million)
- Table 133 France Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 134 France Retail Sales In Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 135 Spain Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 136 Spain Consumables In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 137 Spain Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 138 Spain Sequencing Services In Next Generation Sequencing (Ngs) Market, By Sample, 2022-2031 (Usd Million)
- Table 139 Spain Sequencing Services In Next Generation Sequencing (Ngs) Market, By Method, 2022-2031 (Usd Million)
- Table 140 Spain Data Management Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million)
- Table 141 Spain Instruments In Next Generation Sequencing (Ngs) Market, By Modality, 2022-2031 (Usd Million)
- Table 142 Spain Instruments In Next Generation Sequencing (Ngs) Market, By Mode, 2022-2031 (Usd Million)
- Table 143 Spain Instruments In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million)
- Table 144 Spain Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 145 Spain Sequencing By Synthesis (Sbs) In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 146 Spain Next Generation Sequencing (Ngs) Market, By Application, 2022-2031 (Usd Million)
- Table 147 Spain Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million)
- Table 148 Spain Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Table 149 Spain Drug & Biomarker Discovery In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million)
- Figure 1 Europe Next Generation Sequencing (Ngs) Market: Segmentation
- Figure 2 Europe Next Generation Sequencing (Ngs) Market: Data Triangulation
- Figure 3 Europe Next Generation Sequencing (Ngs) Market: Droc Analysis
- Figure 4 Europe Next Generation Sequencing (Ngs) Market: Europe Vs Regional Market Analysis
- Figure 5 Europe Next Generation Sequencing (Ngs) Market: Company Research Analysis
- Figure 6 Europe Next Generation Sequencing (Ngs) Market: Interview Demographics
- Figure 7 Europe Next Generation Sequencing (Ngs) Market: Market Application Coverage Grid
- Figure 8 Europe Next Generation Sequencing (Ngs) Market: Dbmr Market Position Grid
- Figure 9 Europe Next Generation Sequencing (Ngs) Market: Vendor Share Analysis
- Figure 10 Europe Next Generation Sequencing (Ngs) Market: Segmentation
- Figure 11 Increasing Adoption Of Ngs-based Tests In Oncology, Prenatal Screening, And Infectious Disease Surveillance Is Driving The Growth Of The Europe Next Generation Sequencing (Ngs) Market From 2024 To 2031
- Figure 12 The Product And Service Segment Is Expected To Account For The Largest Share Of The Europe Next Generation Sequencing (Ngs) Market In 2024 And 2031
- Figure 13 Drivers, Restraints, Opportunities And Challenges Of Europe Next Generation Sequencing (Ngs) Market
- Figure 14 Europe Next Generation Sequencing (Ngs) Market: By Product And Service 2023
- Figure 15 Europe Next Generation Sequencing (Ngs) Market: By Product And Services, 2024-2031 (Usd Million)
- Figure 16 Europe Next Generation Sequencing (Ngs) Market: By Product And Service, Cagr (2024-2031)
- Figure 17 Europe Next Generation Sequencing (Ngs) Market By Product And Service, Lifeline Curve
- Figure 18 Europe Next Generation Sequencing (Ngs) Market: By Technology 2023
- Figure 19 Europe Next Generation Sequencing (Ngs) Market: By Technolog, 2024-2031 (Usd Million)
- Figure 20 Europe Next Generation Sequencing (Ngs) Market: By Technolog, Cagr (2024-2031)
- Figure 21 Europe Next Generation Sequencing (Ngs) Market By Technolog, Lifeline Curve
- Figure 22 Europe Next Generation Sequencing (Ngs) Market : By Application, 2023
- Figure 23 Europe Next Generation Sequencing (Ngs) Market : By Application, 2024-2031 (Usd Million)
- Figure 24 Europe Next Generation Sequencing (Ngs) Market : By Application, Cagr (2024-2031)
- Figure 25 Europe Next Generation Sequencing (Ngs) Market : By Application, Lifeline Curve
- Figure 26 Europe Next Generation Sequencing (Ngs) Market : By End User, 2023
- Figure 27 Europe Next Generation Sequencing (Ngs) Market : By End User, 2024-2031 (Usd Million)
- Figure 28 Europe Next Generation Sequencing (Ngs) Market : By End User, Cagr (2024-2031)
- Figure 29 Europe Next Generation Sequencing (Ngs) Market : By End User, Lifeline Curve
- Figure 30 Europe Next Generation Sequencing (Ngs) Market : By Distribution Channel, 2023
- Figure 31 Europe Next Generation Sequencing (Ngs) Market : By Distribution Channel, 2024-2031 (Usd Million)
- Figure 32 Europe Next Generation Sequencing (Ngs) Market : By Distribution Channel, Cagr (2024-2031)
- Figure 33 Europe Next Generation Sequencing (Ngs) Market : By Distribution Channel, Lifeline Curve
- Figure 34 Europe Next Generation Sequencing (Ngs) Market: Snapshot (2023)
- Figure 35 Europe Next Generation Sequencing (Ngs) Market: Company Share 2023 (%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
